FCCC LOGO Faculty Publications
De Bono JS , Petrylak DP , Calvo E , Saad F , Hudes GR , Cooney MM , Pollak MN , Agus DB , Gillessen S , Scranton J
Activity of the anti-IGF-IR antibody CP-751,871 in combinatiion with docetaxel as first-line treatment for castration resistant prostate cancer in a randomized Phase II trial
. 2008 :178-178
PMID: ISI:000261221200562   
Back to previous list
Abstract
Notes
De Bono, J. S. Petrylak, D. P. Calvo, E. Saad, F. Hudes, G. R. Cooney, M. M. Pollak, M. N. Agus, D. B. Gillessen, S. Scranton, J. 0 376ZJ